NLRC4 and neoplasm: Using a fluorescent probe for active CASP1, we also found that obesity-induced CASP1 activation was significantly reduced in CD45+ tumour-infiltrating leukocytes from NLRC4-deficient DIO mice compared with WT DIO mice (Fig. 3h).